American Century Companies Inc. Acquires 4,854 Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Posted by Defense World Staff on Sep 1st, 2023

American Century Companies Inc. raised its holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA – Free Report) by 1.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 258,614 shares of the company’s stock after buying an additional 4,854 shares during the period. American Century Companies Inc. owned about 1.06% of Establishment Labs worth $17,487,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in the business. Citigroup Inc. raised its holdings in shares of Establishment Labs by 221.1% in the 1st quarter. Citigroup Inc. now owns 1,554 shares of the company’s stock worth $105,000 after acquiring an additional 1,070 shares during the last quarter. Credit Suisse AG lifted its holdings in shares of Establishment Labs by 5.7% in the first quarter. Credit Suisse AG now owns 22,682 shares of the company’s stock valued at $1,536,000 after purchasing an additional 1,221 shares in the last quarter. Bessemer Group Inc. bought a new position in shares of Establishment Labs in the first quarter valued at approximately $132,000. Kornitzer Capital Management Inc. KS boosted its position in shares of Establishment Labs by 0.3% during the first quarter. Kornitzer Capital Management Inc. KS now owns 304,380 shares of the company’s stock valued at $20,619,000 after buying an additional 1,050 shares during the last quarter. Finally, Cowen AND Company LLC grew its holdings in Establishment Labs by 1.1% during the first quarter. Cowen AND Company LLC now owns 866,172 shares of the company’s stock worth $58,674,000 after buying an additional 9,518 shares in the last quarter. 71.60% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ESTA has been the topic of several recent analyst reports. Citigroup began coverage on Establishment Labs in a research note on Thursday, June 29th. They set a “buy” rating and a $79.00 price objective on the stock. JPMorgan Chase & Co. initiated coverage on shares of Establishment Labs in a report on Thursday. They set an “overweight” rating and a $75.00 price target on the stock. Finally, Stephens reiterated an “overweight” rating and issued a $89.00 price objective on shares of Establishment Labs in a research note on Friday, July 21st. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $91.60.

View Our Latest Stock Analysis on ESTA

Establishment Labs Trading Up 3.9 %

NASDAQ ESTA opened at $60.37 on Friday. The business’s fifty day moving average is $63.86 and its 200-day moving average is $67.46. The company has a debt-to-equity ratio of 3.32, a current ratio of 4.83 and a quick ratio of 3.53. The stock has a market capitalization of $1.56 billion, a price-to-earnings ratio of -24.74 and a beta of 1.01. Establishment Labs Holdings Inc. has a one year low of $44.03 and a one year high of $79.88.

Establishment Labs (NASDAQ:ESTA – Get Free Report) last posted its quarterly earnings data on Tuesday, August 8th. The company reported ($0.65) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.68) by $0.03. The business had revenue of $48.56 million during the quarter, compared to the consensus estimate of $47.25 million. Establishment Labs had a negative net margin of 34.35% and a negative return on equity of 755.73%. Equities research analysts predict that Establishment Labs Holdings Inc. will post -2.48 EPS for the current year.

Establishment Labs Profile

(Free Report)

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.